UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY;NAVIPHARM CO, LTD
发明人:
KIM, Dong Hyun,HAN, Myung Joo
申请号：
PH12018500566
公开号：
PH12018500566(A1)
申请日:
2018.03.15
申请国别(地区):
菲律宾
年份:
2018
代理人:
摘要：
The present invention provides a novel Lactobacillus sp. strain, a novel Bifidobacterium sp. strain or a lactobacillus mixture thereof, which is isolated from kimchi or human feces. According to the present invention, the specific Lactobacillus sp. strain or the specific Bifidobacterium sp. strain is isolated from kimchi or human feces, thereby having high safety and various physiological activities such as an antioxidant activity, a B-glucuronidase inhibitory activity, a lipopolysaccharide (LPS) generation inhibitory activity or a tight junction protein expression-inducing activity. Therefore, according to the present invention, the specific Lactobacillus sp. strain, the specific Bifidobacterium sp. strain or a lactobacillus mixture thereof can be used as a functional food and drug material useful for preventing, alleviating or treating a bowel injury, a liver injury, allergies, inflammatory diseases or obesity.
